Evaluating and treating anxiety disorders in medical settings.
Anxiety disorders and medical illness present to the primary care physician as a common comorbidity. This article aims to review the literature on the prevalence of anxiety disorders in patients presenting to primary care physicians; to address the key issues in assessing the comorbid condition; and to discuss psychological and pharmacological treatment options for patients with a comorbid anxiety disorder and medical illness. Anxiety disorders are highly prevalent within the primary care population, and these disorders significantly impact the patient's course and outcome. Fortunately, primary care physicians have a variety of effective cognitive, behavioral and pharmacological interventions available for managing these patients with comorbid anxiety and medical illnesses.
Ball
S
S
Department of Psychiatry, Indiana University School of Medicine, 1710 N. Capitol Ave., C-200, Indianapolis, IN 46202, USA.
Goddard
A
A
Shekhar
A
A
D014151:Anti-Anxiety Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000453:epidemiology*; D001569:Benzodiazepines; D015897:Comorbidity; D006801:Humans
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines